New Delhi, Dec 8 (PTI) Pharmaceuticals firm Lupin Ltd on Thursday said it has appointed Spiro Gavaris as president of its US generics business.

Spiro, who had most recently served as president of Specialty Generics business at Mallinckrodt Pharmaceuticals and the president of US Injectables at Hikma, will be responsible for the overall strategy, implementation and growth of Lupin's US generics business, the company said in a regulatory filing.

Also Read | Cyclone Mandous Update: IMD Predicts Heavy Rainfall in Tamil Nadu From December 9 Midnight, Red Alert Issued for Three Districts.

He has significant experience in the branded, generic and biotech industries, it added.

"Spiro brings strong pharma and biotech experience and has an established track record of success in building generics business across platforms, and in particular on the injectables front," Lupin CEO Vinita Gupta said.

Also Read | How To Get Most Out Of Black Friday Deals?.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)